The global gene transfer technologies market, valued at US$3.63 billion in 2023, is forecasted to grow at a robust CAGR of ...

Financial GeoVax Anticipates Significant 2025 Progress With Catalyst-Rich Milestones Across Key Programs 05.02.2025 / 15:06 CET/CEST The issuer is solely responsible for the content of this ...

By leveraging the collective strengths of this alliance, North America positions itself as a global leader in technological ...

Researchers are enhancing the best features of AAV capsids and overcoming their limitations to accelerate gene-based therapies.

Leading organizations across Quebec and the Northeastern states of the United States have joined forces to address trade challenges and strengthen resilience. Recognizing the semiconductor industry as ...

Viralgen and Axovia Therapeutics are joining forces to advance the development and manufacture of an AAV9-based inv ...

Transgene's programs utilize viral vector technology with the goal of indirectly or ... The occurrence of any of these risks could have a significant negative outcome for the Company's activities, ...

According to research from management consultancy Kearney and analyst firm Futurum, big company CEOs are buying into AI hopes and dreams, with a dash of prudence.